DarioHealth Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.8% | +0.5% | +38.6% | +15.8% | +0.3% | -41.2% | -36.1% | -31.8% | -58.5% | +104.0% | +1.1% | – | |
| – | -14.8% | +56.1% | -48.1% | -21.8% | -7.0% | -9.6% | -13.1% | +45.0% | -30.9% | -29.3% | -56.1% | – | |
| – | +138.6% | -319.6% | – | – | +243.1% | -147.4% | – | -133.3% | – | – | +113.8% | – | |
| – | -70.5% | -32.5% | -48.2% | +10.3% | -34.4% | +47.6% | +41.9% | -6.8% | -36.6% | +19.2% | +22.6% | – | |
| – | -70.5% | +10,565.1% | -99.7% | +10.3% | -34.4% | +47.6% | +41.9% | -6.8% | +10,207.3% | -80.5% | +176.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | -100.0% | – | – | -62.8% | -98.2% | +13,926.6% | -100.1% | -100.0% | – | – | |
| – | – | – | – | – | – | -99.2% | -6,655.6% | – | -201.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.